OUTCOME OF PATIENTS WITH TRANSFORMED INDOLENT NON-HODGKIN LYMPHOMA REFERRED FOR AUTOLOGOUS STEM CELL TRANSPLANTATION

被引：0
|
作者：
Villa, D. [1 ]
Crump, M. [1 ]
Keating, A. [1 ]
Ambler, K. [2 ]
Kuruvilla, J. [1 ]
机构：
[1] Princess Margaret Hosp, Div Med Oncol & Hematol, Toronto, ON M4X 1K9, Canada
[2] Univ British Columbia, Dept Hematol, Vancouver, BC V5Z 1M9, Canada
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：188 / 189
页数：2
相关论文
共 50 条
  • [1] Outcome of patients with transformed indolent non-Hodgkin lymphoma referred for autologous stem-cell transplantation
    Villa, D.
    Crump, M.
    Keating, A.
    Panzarella, T.
    Feng, B.
    Kuruvilla, J.
    ANNALS OF ONCOLOGY, 2013, 24 (06) : 1603 - 1609
  • [2] Autologous blood stem cell transplantation for Hodgkin and non-Hodgkin lymphoma: Complications and outcome
    Kumar, Lalit
    Ganessan, Prasanth
    Ghosh, Indraneel
    Panda, Deepanjan
    Gogia, Ajay
    Mandhania, Sushil
    NATIONAL MEDICAL JOURNAL OF INDIA, 2010, 23 (06): : 330 - 335
  • [3] Autologous stem cell transplantation in patients with non-Hodgkin's lymphoma
    Prinz, E
    Mitterbauer, M
    Keil, F
    Kalhs, P
    Mitterbauer, G
    Höcker, P
    Jäger, U
    Chott, A
    Mannhalter, C
    Greinix, H
    BONE MARROW TRANSPLANTATION, 2001, 27 : S272 - S272
  • [4] Allogeneic or autologous haematopoietic stem cell transplantation for non-Hodgkin lymphoma: status at transplantation and outcome
    Ferrant, A
    Van den Neste, E
    Michaux, L
    Durbecq, J
    Latinne, D
    BONE MARROW TRANSPLANTATION, 2004, 33 : S36 - S36
  • [5] Outcome of autologous stem-cell transplantation in Hodgkin and non hodgkin lymphoma patients
    Soyer, N.
    Mutlu, C. Atmaca
    Vural, F.
    Tombuloglu, M.
    Tobu, M.
    Sahin, F.
    Saydam, G.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S289 - S290
  • [6] AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR TRANSFORMED INDOLENT NON-HODGKIN LYMPHOMA: A REPORT OF THE CANADIAN BLOOD AND MARROW TRANSPLANT GROUP (CBMTG)
    Villa, D.
    Savage, K.
    Crump, M.
    Toze, C.
    Rubinger, M.
    Lee, C.
    Alzahrani, M.
    Foley, R.
    Xenocostas, A.
    Sabloff, M.
    Stewart, D.
    Chua, N.
    Couture, F.
    Larouche, J. F.
    Kuruvilla, J.
    ANNALS OF ONCOLOGY, 2011, 22 : 115 - 115
  • [7] Rituximab: Enhancing outcome of autologous stem cell transplantation in non-Hodgkin's lymphoma
    Gisselbrecht, C
    Mounier, N
    SEMINARS IN ONCOLOGY, 2003, 30 (01) : 28 - 33
  • [8] Autologous stem cell transplantation in patients with aggressive non-Hodgkin's lymphoma
    Minigo, H
    Vrhovac, R
    Planinc-Peraica, A
    Ostojic-Kolonic, S
    Radic-Kristo, D
    Maric-Besic, K
    Maglov, C
    Strauss-Patko, M
    Siftar, Z
    Kardum, M
    Kardum-Skelin, I
    Sustercic, D
    Dominis, M
    Kusec, R
    Jaksic, B
    BONE MARROW TRANSPLANTATION, 2001, 27 : S266 - S266
  • [9] Autologous stem cell transplant in first remission for transformed indolent non-Hodgkin lymphoma: additional data to guide practice
    Reneau, John C.
    William, Basem M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (05) : 663 - 665
  • [10] Phase I/II Study of Bortezomib-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Relapsed Indolent Non-Hodgkin Lymphoma, Transformed, or Mantle Cell Lymphoma
    William, Basem M.
    Allen, Mary S.
    Loberiza, Fausto R., Jr.
    Bociek, Robert Gregory
    Bierman, Philip J.
    Armitage, James O.
    Vose, Julie M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (04) : 536 - 542
12345